BIO-TECHNE Corp vs State Street SPDR S&P Homebuilders ETF — how do they compare? BIO-TECHNE Corp trades at $71.58 (market cap $11.24B), while State Street SPDR S&P Homebuilders ETF trades at $110.5. The key difference: BIO-TECHNE Corp pays a 0.44% dividend while State Street SPDR S&P Homebuilders ETF pays none, and BIO-TECHNE Corp is trading nearer its 52-week high, State Street SPDR S&P Homebuilders ETF nearer its low. Which is the better fit depends on your goals.
| TECH | XHB | |
|---|---|---|
Market Cap | $11.24B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $72.29 | $121.36 |
52-Week Low | $43.31 | $94.86 |
Enterprise Value | $11.32B | — |
Dividend Yield | 0.44% | — |
Trailing returns across standard periods
Latest headlines on both assets
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →XHB invests in the U.S. homebuilding industry and related sectors. It provides equal-weighted exposure to homebuilders, building products, and home improvement retailers like Home Depot, Lowe's, and Builders FirstSource.
Read more on XHB →